Prescriber's Corner

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab

Lindsay Hladnik,1 PharmD, BCOP, Kristan Augustin,2 PharmD, BCOP, and Sean DeFrates,3 PharmD, BCOP

1Washington University Medical School, St. Louis, Missouri; 2Barnes-Jewish Hospital, St. Louis, Missouri; 3Northwestern Memorial Hospital, Chicago, Illinois

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

Lindsay Hladnik, PharmD, BCOP, Alvin J. Siteman Cancer Center, Department of Medicine, Division of Medical Oncology, Washington University Medical School, 4921 Parkview Place, Suite 74, St. Louis, MO 63110. E-mail: lhladnik@dom.wustl.edu


doi: 10.6004/jadpro.2016.7.1.6 |


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me